[ad_1]
The European Commission warned Hungary on Thursday that the administration of the imported coronavirus vaccine from Russia poses medical risks and could affect public confidence, Reuters reports, cited by Mediafax.
Hungary imported the first doses of the Russian Sputnik V vaccine on Thursday, as part of a plan that could lead to massive imports and vaccine production in Hungary if it proves safe and effective. “Hungarian experts will have the opportunity to study the vaccine in the next period and make a well-informed decision on the possible use and approval,” said Peter Szijjarto, Hungary’s foreign minister.
But the European Commission has warned the Budapest government about the use of an unauthorized vaccine in the EU. “The question is whether an EU member state would like to give citizens a vaccine that has not been reviewed by the European Medicines Agency,” said a spokesman for the European Commission.
According to European regulations, the Sputnik V vaccine must be authorized by the European Medicines Agency before it can be produced or used in any EU Member State.
This is where the clearance procedure and confidence in the vaccine meet. If our citizens begin to question the safety of a vaccine, if it does not go through rigorous scientific evaluations to demonstrate its safety and efficacy, it will be much more difficult to vaccinate a sufficient proportion of the population. “said the representative of the European Commission.
Russia has announced that intermediate test results show that the Sputnik V vaccine is 92% effective in protecting people from SARS-CoV-2 virus infection.
The European Medicines Agency has announced that it has no data from Russia or Hungary on the Sputnik V vaccine.
Publisher: Liviu Cojan
